Back
SGP

SGP

NASDAQ

SpyGlass Pharma, Inc. Common Stock

23.41

-1.98(-7.8%)
Volume

0.0M

Market Cap

$782.52M

P/E Ratio

-

EPS

-

Price Chart

Price Alerts

No price alerts set. Add an alert to get notified!

Notify when price goes above $120.00
Notify when price goes above $180.00
Notify when price goes below $180.00

Key Financial Ratios

P/E Ratio

-

P/B Ratio

-

EPS

-

ROE

-

Profit Margin

-

Operating Margin

-

Peer Comparison

Compare TSM with similar companies in the sector

Company Price Change % P/E Market Cap D/E

* Peer stocks are selected based on market capitalization and sector

Private Notes

Key Statistics

52 Week High

$32.44

52 Week Low

$20.15

Dividend

-

Dividend Yield

-

About SpyGlass Pharma, Inc. Common Stock

SpyGlass Pharma, Inc. is a late-stage biopharmaceutical, which engages in the development of treatment paradigm for patients living with chronic eye conditions. Its lead product candidate, Bimatoprost Drug Pad-IOL System (BIM-IOL System), is designed to be implanted during routine cataract surgery to reduce elevated intraocular pressure (IOP) for patients who have wither open-angel glaucoma (OAG) or ocular hypertension (OHT). The company was founded in January 2019 by Malik Y. Kahook and Glenn Sussman and is headquartered in Aliso Viejo, CA.